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ABSTRACT: We report DNA binding studies of the
dinuclear ruthenium ligand [{Ru(phen)2}2tpphz]
4+ in enantio-
merically pure forms. As expected from previous studies of
related complexes, both isomers bind with similar aﬃnity to B-
DNA and have enhanced luminescence. However, when tested
against the G-quadruplex from human telomeres (which we
show to form an antiparallel basket structure with a diagonal
loop across one end), the ΛΛ isomer binds approximately 40
times more tightly than the ΔΔ, with a stronger luminescence.
NMR studies show that the complex binds at both ends of the quadruplex. Modeling studies, based on experimentally derived
restraints obtained for the closely related [{Ru(bipy)2}2tpphz]
4+, show that the ΛΛ isomer ﬁts neatly under the diagonal loop,
whereas the ΔΔ isomer is unable to bind here and binds at the lateral loop end. Molecular dynamics simulations show that the
ΔΔ isomer is prevented from binding under the diagonal loop by the rigidity of the loop. We thus present a novel
enantioselective binding substrate for antiparallel basket G-quadruplexes, with features that make it a useful tool for quadruplex
studies.
■ INTRODUCTION
Although it has been known for ﬁve decades that guanine-rich
nucleic acids can form four-stranded structures, research into
quadruplex DNA has rapidly escalated in recent years. One
reason for continued interest is the demonstration that
telomeres can and do fold into quadruplex structures in
vivo.1−3 Shortening of telomeres on chromosomal replication is
considered to be a major cause of senescence, and cancer cells
have been shown to generate an immortal phenotype by
upregulating telomerase.4,5 The activity of telomerase is
inhibited by the presence of G-quadruplexes,6 leading to the
possibility of novel anticancer agents that work by binding to
and stabilizing such quadruplexes.
A second reason for interest is the observation that
quadruplexes are found not only in telomeres but also in
other parts of the genome. Typically they are found in
upstream promoters7−9 and in some cases have been shown to
perform a regulatory function on downstream genes.10−13
Quadruplexes are also formed by RNA and again are likely to
have regulatory roles on translation.14 For all these reasons,
there is considerable interest in ﬁnding small molecules that
bind to quadruplexes and stabilize them and that could act as
markers for their presence.
Over the past few years, it has become abundantly clear that
guanine-rich sequences can fold into quadruplexes in many
diﬀerent ways.15 A given sequence can also fold diﬀerently
depending on solution conditions, including counterions
(potassium or sodium), molecular crowding,16−18 and dehy-
dration.19 A case in point is the human telomere sequence,
HTS, d[AG3(TTAG3)3], which has been observed in several
conformations.20−27 It appears that such behavior is common.28
This plasticity makes it all the more important to identify small
molecules that bind speciﬁcally to particular conformations and
stabilize them, especially if the function and dysfunction of
quadruplexes in normal and abnormal cellular function are to
be delineated.29
Despite this importance, there is little detailed crystallo-
graphic or NMR data on ligand−HTS quadruplex struc-
tures.28,30,31 Of relevance to this work, there is only one report
on metal complexes.32 Only four X-ray structures involving an
intramolecular quadruplex have been reported, all of which
involve the all-parallel conformer with the ligand end-stacking
on terminal G-tetrads.33−36 Although, as outlined above,
telomere sequences can take up a range of topologies, virtually
all the other reported structures also involve ligands bound to
all-parallel conformers, comprising tetramolecular or bimolec-
ular quadruplexes.37−41 Indeed, given this paucity of data and
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the range of potential telomeric conformer targets, it has been
suggested that the design of small molecules to stabilize G-
quadruplexes should also be directed toward ligands that
selectively target antiparallel and hybrid type G-quadruplex
folding topologies.27 The structural data obtained for small
molecules bound to non all-parallel quadruplex conformers
indicate that these telomeric structures could be targeted
through speciﬁc interactions. For example the crystallographic
structures of disubstituted aminoalkylamidoacridine derivatives
bound to the dimeric antiparallel G-quadruplex formed from
the Oxytricha nova telomere sequence d(G4T4G4) reveal that
while these structures display the expected end-stacking
interaction, they also feature a second distinctive motif: the
acridine moiety “threads” through the T4 diagonal loop.
42,43
As part of a program to develop luminescent metal
complexes as sequence and structure speciﬁc DNA binding
substrates,44−46 we have studied the quadruplex binding
properties of dinuclear ruthenium(II) complexes containing
the tetrapyrido[3,2-a:2′,3′-c:3″,2″-h:2‴,3‴-j]phenazine (tpphz)
ligand. Although the central tpphz ligand in such complexes is
planar, the octahedral coordination geometry about the
ruthenium centers gives rise to a “dumbbell” structure with
bulky, and chiral, “stoppers”. These studies have revealed that
both [{Ru(bipy)2}2tpphz]
4+, 1, and [{Ru(phen)2}2tpphz]
4+, 2,
(where bipy = 2,2′-bipyridine, phen = 1,10-phenanthroline),
Figure 1, bind to quadruplex DNA with high aﬃnities (>107
M−1).47
Both these complexes display a “DNA light-switch” eﬀect,
being essentially nonemissive in aqueous solution until DNA
binding induces a several orders of magnitude increase in their
Ru → tpphz 3MLCT-based luminescence. Uniquely, the
emission and binding aﬃnities of 1 and 2 are sensitive to
DNA structure. While groove binding to all duplexes produces
a relatively weak emission at >675 nm, binding to quadruplexes
produces more complex emission changes. Intense blue-shifted
luminescence (∼630 nm) and high aﬃnity binding is observed
only when the complex binds to antiparallel quadruplex
structures containing external diagonal loops at least three
bases in length. The presence of shorter lateral loops limits
binding aﬃnities by several orders of magnitude and results in
negligible emission.48 This diﬀerence in luminescence output
means that, despite the only modest selectivity in binding
aﬃnities, quadruplex structures can be detected in the presence
of duplex DNA. Indeed, this concept has been illustrated by
recently reported cell studies with these complexes.49
Fascinatingly, in cellulo studies reveal that, while 1 is only
taken up by ﬁxed cells, 2 is actively transported into live
cells.49,50 Confocal microscopy studies conﬁrm that 2 is a
selective luminescent stain for heterochromatin. Furthermore, 2
displays distinctive noncolocalized multiple emission peaks,
whose wavelengths are consistent with those obtained through
in vitro studies, indicating that the complex is an in cellulo
probe of DNA structure.49
Until now, these studies have used racemic mixtures of
complexes 1 and 2. However, recently the Qu group have
shown that the ΛΛ-enantiomer of a nonemissive dinuclear
nickel(II) triple helicate complex displays a strong binding
preference for speciﬁc quadruplex structures over duplex
DNA,51,52 while Sugiyama and co-workers have demonstrated
that a chiral helicene macrocycle can enantioselectively
recognize quadruplex DNA.53 Furthermore, recent spectro-
scopic,54,55 crystallographic,56−58 and NMR59 studies on mono-
and dinuclear RuII(dppz) (dppz = dipyrido[3,2-a:2′,3′-c]-
phenazine) systems with duplex DNA have also illustrated
the importance of chirality in such interactions. In light of these
studies, we discuss the DNA binding preferences of
enantiopure samples of 2 and also report NMR-based studies
designed to delineate the structural details of quadruplex
binding by 1 and 2, followed by further rationalization of the
results based on molecular dynamics (MD) simulations in
water.
■ RESULTS AND DISCUSSION
Spectroscopic Binding Studies. In previous studies, we
have found that the luminescent binding response of rac-1 and
rac-2 to duplex and quadruplex DNA is eﬀectively identical. In
both cases, binding to duplex DNA produces a 60-fold increase
in emission, while binding to quadruplex produces a >150 times
increase in blue-shifted emission. Furthermore comparisons of
Kb values for rac-1 and rac-2 revealed they are almost identical
within experimental error.47 In the study reported herein, the
interaction of enantiomerically pure complexes ΔΔ-2 and ΛΛ-
2 with duplex and quadruplex DNA was investigated through
luminescence titrations using calf thymus DNA (CT-DNA)
(Supporting Information Figure S01) and the human telomere
sequence (HTS) d[AG3(TTAG3)3] (Figure 2).
Figure 1. (A) Structures of complexes studied. (B) The two possible enantiomers of each of the metal centers in 1 and 2. (C) Schematic of the two
diastereomers of 1 and 2 relevant to this study: left ΛΛ; right ΔΔ.
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To aid comparisons, data for rac-2 in these conditions are
also included. The CD spectrum of the HTS sequence in
uncrowded K+ solutions conﬁrmed that it adopts an antiparallel
basket conformation (Supporting Information Figure S02),
which is consistent with previous observations by Rencǐuk et
al.26 NMR and CD spectra of HTS in 100 mM NaCl are similar
to those reported by Wang and Patel20 and indicate that the
structure remains an antiparallel basket.
Characteristics for the interaction of CT-DNA with either
enantiomer in aqueous buﬀer solutions were found to be very
similar. Both show a very similar increase in steady-state
luminescence, which is identical within experimental error to
the changes observed for an unresolved diastereomeric mixture
(see Supporting Information). Indeed, ﬁts of the data to
standard binding models lead to estimates of binding aﬃnities
that are almost identical to those previously reported for the
unresolved mixture (Kb = 4.40 × 10
6 M−1), although it does
appear that the binding aﬃnity of ΛΛ-2 is slightly higher than
that of ΔΔ-2 (Table 1).
By contrast, titrations of enantiomerically pure 2 with HTS
produced clear diﬀerences in the luminescent response of ΛΛ-2
and ΔΔ-2. Addition of HTS to ΛΛ-2 led to increases in
emission that were around 20% larger than those observed for
an unresolved diastereomeric mixture. More fascinatingly, ΔΔ-
2 displayed a much smaller emission response than either ΛΛ-2
or the unresolved solution mixture: at binding saturation, the
steady-state emission intensity of ΔΔ-2 is 6-fold less than that
of ΛΛ-2 (Figure 2). Because the binding-induced light-switch
eﬀect observed for these complexes is due to transfer from a
polar bulk aqueous environment into a less polar binding
environment, these data indicate that bound ΔΔ-2 is much
more solvent accessible than ΛΛ-2, thus implying structural
diﬀerences in the binding complexes with HTS for the two
diastereomers. Fits of the luminescence changes to a simple one
set of identical binding sites model oﬀers further evidence to
support this hypothesis, as the binding aﬃnity of ΛΛ-2 is
around 40 times higher than that of ΔΔ-2 (Table 1). The
diastereomeric mixture contains 25% ΛΛ-2, 25% ΔΔ-2, and
50% ΛΔ-2, yet its emission intensity is roughly 85% the
intensity of pure ΛΛ-2. This is almost exactly the value
expected if ΛΔ-2 has the same emission intensity as ΛΛ-2. The
results therefore suggest that ΛΔ-2 binds in the same way as
ΛΛ-2, i.e., that for binding to HTS, Δ chirality is possible at
one end of the ligand but not both.
As discussed before, addition of 2 (as a racemic mixture or as
pure enantiomers) gives rise to hypochromic and bathochromic
shifts in UV−vis spectra, indicative of stacking of the aromatic
rings against DNA base pairs. A stacking mode of binding is
also indicated by the strongly enhanced luminescence and the
blue-shift of approximately 30 nm, which we have shown only
occurs when the ligand is strongly shielded from solvent.48
Shielding to this extent can only arise when the ligand is
covered by quadruplex loops: in other words, it implies stacking
over a tetrad plane and shielding by loops, rather than groove
binding. Furthermore, the markedly greater increase in
luminescence for bound ΛΛ-2 implies signiﬁcantly better
shielding from solvent for this isomer. Further evidence for this
hypothesis was obtained by NMR studies
NMR Binding Studies. To provide structural insights into
the eﬀects observed in our optical studies, the binding of 1 and
2 to HTS was further investigated using a combination of NMR
spectroscopy and simulated annealing coupled with restrained
molecular dynamics simulations for structure determination.
Assignments of the folded quadruplex before addition of any
complex are given in the Supporting Information (Table S1).
On addition of ΔΔ-2 to HTS, severe line broadening of
DNA signals was observed by NMR, mainly from the lateral
loop end (red dots, bottom end of Figure 3). This implies that
the ligand is binding at this end and causing structural
perturbations concomitant with binding, which occur on a time
scale in the millisecond range. Unfortunately, this is a common
observation in studies of DNA/ligand interactions and it makes
structure determination of the complexes diﬃcult by severely
reducing the information content of spectra. By contrast,
addition of the more tightly binding ΛΛ-2 produced less severe
relaxation-induced broadening although enough to abolish
intermolecular NOEs. Chemical shift changes occurred at both
ends of the quadruplex, and intramolecular NOEs were
broadened and lost at both ends. It therefore appears that
whereas ΔΔ-2 binds mainly at the lateral loop end, ΛΛ-2 binds
at both ends. Taken together with the luminescence data, the
implication is that binding of ΛΛ-2 at the diagonal loop end
(top end of Figure 3) is accompanied by a high degree of
shielding of the ligand from solvent. This in turn implies that
the ligand is stacked onto the tetrad underneath the diagonal
loop.
All attempts to alter the solution conditions so as to bring
back intermolecular NOEs were unsuccessful. We therefore
carried out titrations with 1. The absorption and emission
response of this complex to HTS binding is very similar to that
of 2: in particular, the enhancement and blue-shifting of its
Figure 2. Typical data for the luminescence response of ΛΛ-2, ΔΔ-2,
and an unresolved diastereomeric mixture of 2 to the progressive
addition of the unimolecular HTS quadruplex d[AG3(TTAG3)3].
Conditions: 10 mM KH2PO4/K2HPO4, 1 mM K2EDTA, 200 mM
KCl, pH 7.0, 298 K, [complex] = 7 μM. Lines show ﬁtted Kb.
Table 1. Estimated Binding Aﬃnities for Diﬀerent
Diastereomers of 2 with Duplex and Quadruplex DNAa
complex Kb(CT-DNA); M
−1 Kb(HTS); M
−1
ΛΛ-2 6.73 × 106 1.16 × 107
ΔΔ-2 1.99 × 106 2.95 × 105
unresolved 2b 6.68 × 106 1.77 × 107
aCalculated errors in estimates of Kb ≈ ±20%. bBinding constants for
diastereomeric mixture are apparent Kbs.
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luminescence are very similar, indicating analogous modes of
binding.48 These studies were carried out on a diastereomeric
mixture as this had the advantage that both putative binding
sites could be potentially investigated in a single experiment.
Addition of 1 to HTS gave rise to chemical shift changes at
both ends of the quadruplex. There was broadening of signals
throughout, which led to a general reduction in the intensities
of intramolecular NOEs, although the largest eﬀects were seen
at the lateral loop end (Table 2). However, gratifyingly, a large
number of new intermolecular NOEs could be seen to the
ligand (Figure 4).
In free solution, NMR resonances from the four symmetry-
related positions of 1 have identical chemical shifts. However,
in the presence of HTS, most signals were split into four, in
some cases with fairly large chemical shift changes. The
increased complexity made it impossible to assign the ligand
signals in the complex to individual positions and meant that,
although we were able to observe 20 intermolecular NOEs in
the complex, we were only able to assign the nucleotide signals
(Table 2).
Analysis of the NOEs reveals that they are not compatible
with a single structure for the complex, because 13 derive from
contacts at the diagonal loop end and seven from contacts at
the lateral loop end. On the basis of the discussion above, this is
not surprising. In particular, by analogy with 2, we expect ΔΔ-1
to bind mainly at the lateral loop end and ΛΛ-1 (and probably
also ΛΔ-1) mainly at the diagonal loop end. NOE intensities
are compatible with this expectation. As anticipated, the NOEs
at the diagonal loop end are consistent with 1 binding under
the diagonal loop.
NMR-Based Structures of Complexes. The experimen-
tally observed NOEs from the lateral loop end were used to
calculate structures for both ΛΛ-1 and ΔΔ-1 bound at the
lateral loop end using restrained simulated annealing. The
structure generated for ΔΔ-1 is shown in Figure 5 and has no
violations of the NOE constraints greater than 0.5 Å.
While the tpphz ligand stacks on top of the tetrad bases, this
interaction is reinforced by electrostatics: the positively charged
ruthenium centers are located at the edge of the tetrad close to
the anionic phosphate backbone. There is little perturbation to
the quadruplex structure, with slight movement of the lateral
loops to accommodate the ligand. Bases in the loops partially
shield the tpphz rings, as expected from the luminescence.
There is little direct contact between the bipy ligands and the
quadruplex, and therefore both the ΛΛ and ΔΔ complexes
bind in a similar way, with similar energies.
The observed NOEs were also used to calculate a structure
for the complex bound at the diagonal loop end. The bound
ΛΛ-1 structure is shown in Figure 6. The bipy rings ﬁt neatly
against the phosphate backbone making close van der Waals
contact. The diagonal loop holds the tpphz in place and shields
it from solvent, as expected from the luminescence data.
By contrast, attempts to use the same NOEs to calculate a
structure with ΔΔ-1 bound at the same site result in a very
high-energy state (roughly 10 times higher). In this structure,
one end of the ligand is able to ﬁt straightforwardly, by
displacing the terminal nucleotide of the quadruplex DNA
chain (Figure 7). However, in this calculation, the other end of
the ligand does not displace the DNA backbone. Instead, the
calculation generates a number of physically impossible
solutions, of which the lowest energy is shown in Figure 7:
the phosphate backbone passes through the middle of one of
the aromatic bipy rings. The other solution is to displace one
bipy ligand completely away from the tpphz plane. Structures
have been calculated for the ΛΛ and ΔΔ isomers of 2 in the
same way and show similar features (Supporting Information
Figures S04 and S05). These calculations imply that the
experimental NOE data are compatible with the ΛΛ isomer
binding at the diagonal loop end but not with the ΔΔ isomer
binding at the same site. This result is thus in agreement with
the conclusion reached above, that both isomers bind at the
Figure 3. The antiparallel basket formed by HTS. The colors show the
residues still present (green), missing (red), and possible exchange
doublet (yellow), upon addition of ΔΔ-2.
Table 2. Intermolecular NOE Crosspeaks and the
Corresponding DNA Residues Identiﬁed for the Interaction
of 1 with HTS
complex signal DNA signal assigned DNA atom
One-Loop End
7.79 4.38 G10 H5′
7.79 2.89 G14 H2′
7.79 2.74 G14 H2″
7.80 5.65 T11 H1′
7.80 6.30 G10 H1′
7.76 6.31 G10 H1′
7.74 3.31 G22 H2′
7.55 2.40 G22 H2″
6.95 5.58 T12 H1′
6.95 1.14 T12 H2′
6.29 5.46 G2 H1′
8.36 2.61 G9 H2″
8.36 2.94 G9 H2′
Two-Loop End
8.36 2.51 G8 H2″
8.36 3.08 G8 H2′
8.11 1.91 T5 CH3
6.93 1.30 T18 H2′
6.93 2.07 T17 CH3
6.93 4.04 T6 H5′*
8.22 2.83 A19 H2′
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lateral loop end, but only the ΛΛ isomer (and probably the ΛΔ
isomer also) binds at the diagonal loop end. To investigate this
issue further, unconstrained molecular dynamics simulations
were carried out in a TIP3P water model.
Unconstrained MD Simulations. To evaluate the impact
of ΛΛ-1 and ΔΔ-1 complexes on the quadruplex structure
when binding under the diagonal loop, molecular dynamics
simulations were performed on free HTS and its association
with ΛΛ-1 and ΔΔ-1. For free HTS, three independent
simulations were undertaken using the structures presented in
Figures 5−7 (henceforth denoted A, B, and C) as starting
conformations. These results were then compared with
simulations of the associations formed between the quadruplex
and both diastereomers ΛΛ-1 and ΔΔ-1, labeled ΛΛ-1-HTS
and ΔΔ-1-HTS, respectively. For the ΛΛ-1-HTS simulation,
the NMR-based structure shown in Figure 6 was used as
starting point, while for simulation of ΔΔ-1-HTS, the starting
structure was generated from ΛΛ-1-HTS by replacing ΛΛ-1
with ΔΔ-1, superimposing the two ruthenium atoms and the
Figure 4. Selected sections of spectra showing the new crosspeaks identiﬁed upon addition of a diastereomeric mixture of 1 to the HTS sequence.
Figure 5. Molecular dynamics-based structure of ΔΔ-1 bound to the
lateral loop end of HTS, generated using experimentally observed
NOEs for the interaction.
Figure 6. Molecular dynamics-based structure of ΛΛ-1 bound to the
diagonal loop end of HTS, generated using experimentally observed
NOEs for the interaction. Left: Illustrating the bipy ring at front left
parallel to the DNA backbone. Right: Showing how the 5′ end of the
DNA backbone (front center) moves to avoid the ligand.
Figure 7. Molecular dynamics-based structure of ΔΔ-1 bound to the
diagonal loop end of HTS, generated using experimentally observed
NOEs for the interaction.
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tpphz bridging ligand. Thus, only the spatial arrangement of the
two Ru(bipy)2 moieties was changed, in agreement with the
respective diastereomers in the octahedral metal coordination
sphere. Further molecular dynamics simulation details, together
with an extended discussion, are provided in Supporting
Information.
Simulations A, B, and C of the free HTS show that the G-
tetrads yield low root mean-square deviations (RMSD),
calculated relative to the starting structures, consistent with a
minor conformational rearrangement experienced by these
subunits throughout the 50 ns of simulation time, which is to
be expected because they are held in place by hydrogen bonds.
In contrast, the diagonal loops are more mobile (see
Supporting Information Figure S06) showing higher RMSD
values. Overall, the three independent simulations sampled
signiﬁcant HTS conformational space as suggested by the
representative conformations of simulations A, B, and C, which
have slightly diﬀerent structures with cross RMSD values
collected in Supporting Information Table S03 between 2.71
and 3.88 Å. We then went on to look at the interaction of HTS
with the metal complex using the same method.
Figure 8 shows the RMSD values over the simulation time
(using the unrelaxed starting structures as reference) for both
the ΛΛ-1-HTS and ΔΔ-1-HTS associations. In both cases,
after an initial jump due to the geometry relaxation using the
ideal force ﬁeld parameters, the values tend to stabilize.
Focusing on the RMSD values for ΛΛ-1-HTS, the G-tetrad and
the HTS structure typically stabilize after the ﬁrst ﬁve ns while
the values for the diagonal loop oscillate. This loop mobility is
assigned to the presence of ΛΛ-1, as it was not observed in
simulations A, B, and C of free HTS. Apart from this increased
loop mobility, the antiparallel basket is as stable as free HTS
was in simulations A, B, and C, so unsurprisingly the RMSDs
between the representative conformations of ΛΛ-1-HTS and
simulations A, B, and C are within the variability found for the
calculated cross RMSDs obtained in these three simulations
(see Supporting Information Table S03).
By contrast, for ΔΔ-1-HTS, all the RMSD values converge
very quickly, including those associated with the diagonal loop.
This indicates that complex ΔΔ-1 is able to ﬁt under the loop
without causing major G-DNA conformational changes.
Indeed, the representative conformation is comparable to the
representative conformation of the ΛΛ-1-HTS simulation
(with a RMSD value of only 1.55 Å) and the representative
frames of the free HTS simulationsm A, B, and C, with cross
RMSD values ranging from 1.54 to 2.81 Å. This indicates that
the observed experimental recognition of only ΛΛ-1 under the
diagonal loop is not caused by the intrinsic loop cavity shape or
size because both isomers are able to ﬁt into the cavity.
Analyzing the representative conformations of ΛΛ-1-HTS
and ΔΔ-1-HTS represented in Figure 9, both ruthenium
complexes bind under the diagonal loop with the tpphz ligand
stacking over the top G-tetrad. However, some diﬀerences are
evident. Complex ΛΛ-1 adopts a diagonal arrangement over
Figure 8. Variation of the RMSD values throughout the course of the MD simulations for ΛΛ-1-HTS (left) and ΔΔ-1-HTS (right). The vertical
black line marks the separation between the equilibration and collection simulation stages.
Figure 9. Representative snapshots of simulations ΛΛ-1-HTS (top, magenta) and ΔΔ-1-HTS (bottom, aquamarine). Side and top views are
presented on the left and center, respectively. Right pictures represent the complexes stacked over the top G-quartet.
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the guanine bases and under the loop whereas in ΔΔ-1, the
stacking of the tpphz ligand is more localized over two guanines
of only one-half of the G-tetrad.
To clarify this point, a surface representation was constructed
for the position occupied by the tpphz ligand (excluding the
hydrogen atoms) over a 50 ns collection period for the HTS
association with each of the diastereomers (Figure 10). These
surfaces clearly show a striking diﬀerence: in ΛΛ-1-HTS, the
tpphz ligand is able to “ﬂoat” over the G-tetrad interacting with
the four guanines. In contrast, in ΔΔ-1-HTS, the tpphz ligand
remains “locked” over two guanines of the G-tetrad throughout
the entire simulation time. Because tpphz is present in both
dinuclear complexes, the diﬀerence in dynamic behavior must
be caused by the stereochemistry of the bipy ligands in the
octahedral Ru(II) coordination spheres. This is consistent with
the observation that in ΛΛ-1-HTS the diagonal loop appears to
be more ﬂexible, oscillating over the middle of both Ru(bipy)2
moieties. On the other hand, in ΔΔ-1-HTS, the loop is more
rigid and locks the ΔΔ-1 complex movement over the G-tetrad.
The above results suggest that, although both ΛΛ-1 and ΔΔ-
1 complexes can ﬁt under the loop, suﬃcient HTS loop
conformational freedom to permit the complex entrance into
the prefolded G-DNA structure is only present for ΛΛ-1. In
contrast, the stereochemistry of ΔΔ-1 appears to induce
increased rigidity on the loop, preventing complex entrance
into the loop arch. In other words, ΔΔ-1 does not bind under
the diagonal loop because the loop arch does not fulﬁll the
complex’s “stereochemical requirements”.
As mentioned above, the simulated annealing structure
proposed for the binding of ΔΔ-1 to the diagonal loop end of
HTS corresponds to an impossible solution (Figure 7), which
could also be rationalized by our unconstrained MD
simulations in water. If one calculates the expected NOEs
(not shown) from the representative conformations of
simulations ΛΛ-1-HTS and ΔΔ-1-HTS (or from the relaxed
structures obtained by Molecular Mechanics minimization), the
protons that contact the ligand are quite diﬀerent, meaning that
the interaction of ΛΛ-1 and ΔΔ-1 under the loop results in
clearly distinct NOEs. Therefore, the experimental interactions
(presumably generated only by the “ΛΛ-1-HTS” interaction)
are not suitable as restraints to generate a hypothetical “ΔΔ-1-
HTS” association with this binding mode.
■ CONCLUSIONS
We have shown that ΛΛ-2 binds mainly at the diagonal loop
end of HTS, stabilized by a good steric ﬁt under the loop. By
contrast, ΔΔ-2 binds >40-fold more weakly and almost entirely
at the other end. Both isomers also bind to B-DNA, but the
aﬃnity of ΛΛ-2 is greater for HTS than for B-DNA and,
importantly, when bound to HTS the luminescence is more
intense and is blue-shifted from ∼675 to ∼630 nm. Studies with
other ligands that bind to quadruplex DNA have shown that
compounds that bind strongly to one conformation also
stabilize that conformation, as expected from thermodynamic
arguments.10,52,60−62 We have previously shown49,50 that 2 is
actively taken up by cells, and confocal images show that it
generates punctate images centered mainly in the hetero-
chromatin, as might be expected for a probe that highlights G-
quadruplexes. It also has a wavelength and intensity of emission
that is diﬀerent for diﬀerent quadruplex structures.48 ΛΛ-2 is
therefore a useful tool for speciﬁcally stabilizing and imaging
antiparallel basket structures with a diagonal loop. This study
also conﬁrms that the antiparallel structure of HTS can be
selectively targeted. In comparison with the use of antibodies to
detect quadruplexes,63−65 small molecules like complex 2 and
its analogues are much simpler to rationally design and
potentially have wider applicability as they can be used directly
on living cells. Furthermore, and as this study indicates, because
such systems can be made to target speciﬁc features of a
quadruplex, they can be made speciﬁc to individual quadruplex
structures. Consequently, with the structural information
obtained by this study, we are exploring this potential for
enhanced speciﬁcity through informed design of derivatives of
2. Although this work is intended to image antiparallel basket
quadruplexes in living cells, it could subsequently be extended
into molecular tools for selectively stabilizing quadruplexes.
■ EXPERIMENTAL SECTION
Ligands were synthesized using published methods. Ru(phen)2Cl2·
2H2O and Ru(bipy)2Cl2·2H2O were prepared following a standard
literature method.64 The racemic mixtures of the tpphz complexes
were prepared by methods we have previously described.47
Enantiomers of 2 were prepared by the route ﬁrst described by
MacDonnell and Bodige.66 Characterization data for these complexes
were identical to the original reports.
The HTS oligonucleotide d[AG3(TTAG3)3] was purchased from
Eurogentec Biotechnology (Southampton, UK), puriﬁed by HPLC,
and used without further annealing. Samples for UV−vis and
luminescence titrations were in 10 mM KH2PO4/K2HPO4 and 1
mM K2EDTA in 50−200 mM KCl (pH 7.0, 298 K), in which DNA
was added to 10 μM ligand, while samples for NMR were prepared in
50 mM NaCl, pH 7, using 300 mM DNA at 298 K. Titrations were
conducted with DNA and ligand of the same order of concentration as
1/Kb, shown to be the optimum values for obtaining accurate binding
constants.67 The optimum temperature for observing NOEs to 1 was
283 K. CD spectra were recorded on a Jasco J-810 spectrophotometer
using a Peltier variable temperature controller: 100 nm/min from 200
to 320 nm. CD melting experiments gave a melting temperature of
63.3 °C. Luminescence measurements were carried out on a Hitachi F-
4500 ﬂuorescence spectrophotometer using a 1 cm path length. UV−
vis titrations were carried out using a Cary 3 Bio. Binding aﬃnities
were obtained by ﬁtting using Origin 7.0 software to a standard one-
set-of-binding-sites model.
NMR experiments were carried out on Bruker Avance 800, 600, and
500 spectrometers. Assignments were made using COSY, TOCSY,
and NOESY spectra (mixing times 60 or 90 ms for TOCSY, 100 ms
for NOESY), supported by 1H−31P HSQC (Supporting Information
Table S01). Spectra were analyzed using FELIX (Felix NMR, Inc., San
Diego, CA).
Structure calculations were carried out using Xplor with the
parallhdg.dna parameters. Calculations used simulated annealing over
8000 steps from 2000 to 100 K, using standard square-well potentials
Figure 10. Surface (isovalue = 1) representing the histogram of
positions occupied by the tpphz atoms (excluding hydrogen) over the
50 ns collection period in ΛΛ-1-HTS (left) and ΔΔ-1-HTS (right).
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for NOEs. All calculations imposed planarity and hydrogen bonding in
the tetrads plus planarity in tpphz and bipy polypyridyl ligands and
octahedral geometry around the ruthenium. The force ﬁeld included
van der Waals and electrostatic terms. Threading of the ligand into the
complex was accomplished by starting with almost zero van der Waals
radii and increasing the radius in a geometric progression during the
simulated annealing. For each complex, only the intermolecular NOEs
relevant to that end were included, all speciﬁed as ambiguous NOEs to
any ligand proton, with an upper limit of 5 Å. Convergence was
improved by including restraints to position the tpphz ring close to the
relevant tetrad plane. NOEs for the ΛΛ-1-HTS and ΔΔ-1-HTS
complexes were calculated by numerical integration of the Solomon
equations.68
Unconstrained MD simulations were carried out using the AMBER
ﬀ99bsc0 set of parameters and charges for DNA69 combined with
General Amber Force Field (GAFF) parameters70 with extra terms71,72
and RESP charges73 for both ΔΔ-1 and ΛΛ-1 complexes. These
simulations were undertaken with the pmemd.cuda AMBER
executable, able to accelerate explicit solvent Particle Mesh Ewald
(PME)74,75 calculations through the use of GPUs with the new Single
Precision Fixed Point (SPFP) model.76
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